BECTON DICKINSON & CO — Director's Dealing 2022

Sep 14, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2022-09-06

Reporting Person: Garrison Michael David (EVP and President Medical)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4477	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Rights to Common Stock Under BD Deferred Compensation Plan	$0		Common Stock (2997)		Direct
Stock Appreciation Rights	$147.68	2025-11-26	Common Stock (6360)		Direct
Stock Appreciation Rights	$167.91	2026-11-26	Common Stock (3054)		Direct
Stock Appreciation Rights	$222.60	2027-11-26	Common Stock (3252)		Direct
Stock Appreciation Rights	$238.16	2028-11-26	Common Stock (2801)		Direct
Stock Appreciation Rights	$251.06	2029-11-26	Common Stock (8023)		Direct
Stock Appreciation	$223.77	2030-11-26	Common Stock (10934)		Direct
Stock Appreciation	$241.10	2031-11-26	Common Stock (7966)		Direct

Footnotes

F1: Includes shares held directly and restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2: The securities are distributed following termination of the reporting person's service, or on the date or dates specified by the reporting person.

F3: The stock appreciation rights vest in four annual installments beginning one year from the date of grant.